Glucagon receptor antagonism induces increased cholesterol absorption.
about
Glucagon orchestrates stress-induced hyperglycaemiaThe Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and MonkeysThe role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities.Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.The New Biology and Pharmacology of Glucagon.Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.Regulation of hepatic glucose metabolism in health and disease.Glucagon like receptor 1/ glucagon dual agonist acutely enhanced hepatic lipid clearance and suppressed de novo lipogenesis in mice.Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes.Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).A first-in-human pharmacodynamic and pharmacokinetic study of a fully human anti-glucagon receptor monoclonal antibody in normal healthy volunteers.Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic Mice.Problem or solution: The strange story of glucagon.Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists.Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function.A large electronic-health-record-based genome-wide study of serum lipids.GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomyGlucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21The first pediatric case of glucagon receptor defect due to biallelic mutations in is identified by newborn screening of elevated arginine
P2860
Q28068879-F1769F71-87B8-4F15-A812-908020176686Q36151024-1E881F12-0C5C-4424-9FE7-BEAEAEBB0B12Q37024780-9FCF838E-63A4-404D-8196-5D074323A390Q38795246-BE5AF307-DB72-4FDD-AECB-D3A323A5F0C2Q38919742-D09E2BDD-5F9F-4A06-8FCD-9F9DE76BC6EFQ38925481-DB68E3C8-ECAB-482E-B907-A6CFF7DC9829Q39450184-68106CEC-7A4D-40F0-B682-C394285A023DQ47128086-CE16924F-C748-4BEF-ABE9-24FDE6C99620Q47625288-15E9C706-BF64-4324-B910-B6126828E77AQ48171528-DB38F1BE-FE0D-4854-99FA-CCEEE88C24C5Q48326278-0271302F-20AA-49FF-A978-A9D3EB5B81D8Q49997196-30143DD4-74A7-4B10-AD3F-7881540D9463Q50140641-B90ABE64-D570-4860-A04F-BD9DD54E49ACQ51286181-6BA20AE4-0C6F-4738-B8BD-6CDE75967E01Q51689139-BCAB4104-0F6C-42E6-8199-77690ADB852EQ52674221-3B4F0CF7-04B8-48DF-9A0B-19DAB1B18991Q53700633-E6583018-3BE6-48FA-8296-187ED84169AAQ57107215-9E13F9F2-9FE1-4FFF-9AB7-0E1AAFA65E59Q57109437-4EEFC210-B780-4D0D-8990-D662227C3017Q57189446-31D432EE-18B7-4528-9C72-DC52A9E6F94F
P2860
Glucagon receptor antagonism induces increased cholesterol absorption.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glucagon receptor antagonism induces increased cholesterol absorption.
@ast
Glucagon receptor antagonism induces increased cholesterol absorption.
@en
type
label
Glucagon receptor antagonism induces increased cholesterol absorption.
@ast
Glucagon receptor antagonism induces increased cholesterol absorption.
@en
prefLabel
Glucagon receptor antagonism induces increased cholesterol absorption.
@ast
Glucagon receptor antagonism induces increased cholesterol absorption.
@en
P2093
P2860
P356
P1476
Glucagon receptor antagonism induces increased cholesterol absorption.
@en
P2093
Daphne Szeto
David E Kelley
Gail Forrest
Harry R Davis
Hong-Ping Guan
Jing Chen Xiao
Jose M Castro-Perez
Kithsiri Herath
P2860
P304
P356
10.1194/JLR.M060897
P577
2015-09-15T00:00:00Z